BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20211557)

  • 1. Common alleles of predisposition in endocrine neoplasia.
    Eng C
    Curr Opin Genet Dev; 2010 Jun; 20(3):251-6. PubMed ID: 20211557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenic patterns of genetic predisposition to endocrine tumors].
    Calender A
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S127-36. PubMed ID: 17373213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multiple endocrine neoplasia: genetic aspects].
    Calender A;
    Bull Acad Natl Med; 2010 Jan; 194(1):81-95; discussion 95-6. PubMed ID: 20669561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
    Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
    J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 "Janus" genetic variation.
    Moore SW; Zaahl M
    J Pediatr Surg; 2010 Feb; 45(2):393-6. PubMed ID: 20152359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?
    Shifrin AL; Xenachis C; Fay A; Matulewicz TJ; Kuo YH; Vernick JJ
    Surgery; 2009 Dec; 146(6):998-1005. PubMed ID: 19958926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
    Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP
    Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary endocrine tumour diseases].
    Husebye ES; Varhaug JE; Heimdal K
    Tidsskr Nor Laegeforen; 2005 Nov; 125(21):2964-7. PubMed ID: 16276382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma.
    Allen SM; Bodenner D; Suen JY; Richter GT
    Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic aspects of familial thyroid cancer.
    Morrison PJ; Atkinson AB
    Oncologist; 2009 Jun; 14(6):571-7. PubMed ID: 19465682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW; Appfelstaedt J; Zaahl MG
    J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of medullary thyroid cancer].
    Fujita T; Fujimori M
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1627-31. PubMed ID: 19838021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medullary thyroid carcinoma and some of its particularities].
    Sidibé el H
    Sante; 2007; 17(1):51-5. PubMed ID: 17897902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasias.
    Phay JE; Moley JF; Lairmore TC
    Semin Surg Oncol; 2000 Jun; 18(4):324-32. PubMed ID: 10805954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The surgical management of medullary thyroid cancer.
    Dackiw AP
    Otolaryngol Clin North Am; 2010 Apr; 43(2):365-74, ix. PubMed ID: 20510719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The RET gene and medullary thyroid cancer: from mutations to the planning of therapy].
    Conzo G; Ruggiero R; Palazzo A; Della Pietra C; Stanzione F; Livrea A; Docimo G
    Chir Ital; 2009; 61(5-6):531-8. PubMed ID: 20380254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of medullary thyroid cancer.
    Sippel RS; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular advances in medullary thyroid cancer diagnostics.
    Hubner RA; Houlston RS
    Clin Chim Acta; 2006 Aug; 370(1-2):2-8. PubMed ID: 16519882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dog pedigree with familial medullary thyroid cancer.
    Lee JJ; Larsson C; Lui WO; Höög A; Von Euler H
    Int J Oncol; 2006 Nov; 29(5):1173-82. PubMed ID: 17016649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.